Model-based development of a PPARgamma agonist, rivoglitazone, to aid dose selection and optimize clinical trial designs (Q40035117)
Jump to navigation
Jump to search
scientific article published on 20 October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Model-based development of a PPARgamma agonist, rivoglitazone, to aid dose selection and optimize clinical trial designs |
scientific article published on 20 October 2008 |
Statements
1 reference
Model-based development of a PPARgamma agonist, rivoglitazone, to aid dose selection and optimize clinical trial designs (English)
1 reference
Kenneth Truitt
1 reference
William J Jusko
1 reference
Shashank Rohatagi
1 reference
Timothy J Carrothers
1 reference
Jinyan Jin
1 reference
Tatiana Khariton
1 reference
Joseph Walker
1 reference
Daniel E Salazar
1 reference
20 October 2008
1 reference
1 reference
48
1 reference
12
1 reference
1420-1429
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference